SE7701045L - PROSTANIC ACID DERIVATIVES - Google Patents
PROSTANIC ACID DERIVATIVESInfo
- Publication number
- SE7701045L SE7701045L SE7701045A SE7701045A SE7701045L SE 7701045 L SE7701045 L SE 7701045L SE 7701045 A SE7701045 A SE 7701045A SE 7701045 A SE7701045 A SE 7701045A SE 7701045 L SE7701045 L SE 7701045L
- Authority
- SE
- Sweden
- Prior art keywords
- formula
- image
- iodine
- compounds
- bound
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 150000003180 prostaglandins Chemical class 0.000 abstract 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- 239000004593 Epoxy Substances 0.000 abstract 1
- 229930194542 Keto Natural products 0.000 abstract 1
- 230000004520 agglutination Effects 0.000 abstract 1
- 210000001772 blood platelet Anatomy 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 238000005695 dehalogenation reaction Methods 0.000 abstract 1
- 210000004051 gastric juice Anatomy 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 230000026045 iodination Effects 0.000 abstract 1
- 238000006192 iodination reaction Methods 0.000 abstract 1
- 150000002496 iodine Chemical class 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 150000002497 iodine compounds Chemical class 0.000 abstract 1
- -1 keto compound Chemical class 0.000 abstract 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 230000017105 transposition Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
- C07D307/937—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Epoxy Compounds (AREA)
Abstract
The novel iodine derivatives of the prostaglandins of the formula I, which possess a 9-deoxy-6,9-epoxy functionality, <IMAGE> in which D, L, Q, X, V, W, R1 and R4 have the same meaning as in Patent Claim 1, are prepared by subjecting a compound of the formula XIII <IMAGE> to an iodination and cyclisation. By reacting with a dehydroiodinating reagent, the halogen atom which is bound to the carbon atom of the cyclic structure, together with the iodine atom which is bound to the adjacent carbon atom, can be eliminated from the iodine compounds of the formula I, with the corresponding compounds possessing a double bond in the trans position being obtained. If, on the other hand, the compounds of the formula I are subjected to a dehalogenation and hydrolysis, the hemiketal of the formula III <IMAGE> is then obtained, mixed with the corresponding open-chain keto compound. The novel prostaglandin derivatives can be used for preventing blood platelet agglutination, for stimulating the smooth musculature, as agents for lowering blood pressure, or as agents for preventing too strong a secretion of gastric juice.
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65511076A | 1976-02-04 | 1976-02-04 | |
| US71677176A | 1976-08-23 | 1976-08-23 | |
| US71677076A | 1976-08-23 | 1976-08-23 | |
| US71697276A | 1976-08-23 | 1976-08-23 | |
| US71696976A | 1976-08-23 | 1976-08-23 | |
| US71696076A | 1976-08-23 | 1976-08-23 | |
| US72554876A | 1976-09-22 | 1976-09-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7701045L true SE7701045L (en) | 1977-08-05 |
| SE435281B SE435281B (en) | 1984-09-17 |
Family
ID=27569874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7701045A SE435281B (en) | 1976-02-04 | 1977-02-01 | PROCEDURE FOR PREPARATION OF PROSTAGLAND INGREDIENTS |
Country Status (13)
| Country | Link |
|---|---|
| JP (1) | JPS5936911B2 (en) |
| BE (1) | BE851122A (en) |
| CA (3) | CA1160627A (en) |
| CH (2) | CH632245A5 (en) |
| DE (1) | DE2702553C2 (en) |
| FR (3) | FR2359125B1 (en) |
| GB (1) | GB1554044A (en) |
| HK (1) | HK9385A (en) |
| IL (1) | IL51189A (en) |
| MX (1) | MX4811E (en) |
| NL (2) | NL185515C (en) |
| NZ (1) | NZ183050A (en) |
| SE (1) | SE435281B (en) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1583961A (en) * | 1976-05-11 | 1981-02-04 | Wellcome Found | Prostacyclin and derivatives thereof |
| NL7705143A (en) * | 1976-05-11 | 1977-11-15 | Wellcome Found | PROCEDURE FOR PREPARING NEW PROSTAGLANDIN DERIVATIVES. |
| GB1595056A (en) * | 1976-10-12 | 1981-08-05 | Wellcome Found | Pharmaceutical combination |
| AU511711B2 (en) * | 1976-12-30 | 1980-09-04 | Upjohn Company, The | 6-Oxo and 5, 6-Dihalo prostaglandin analogues |
| FI71138C (en) * | 1976-12-31 | 1986-11-24 | Erba Farmitalia | FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT ACTIVE BISYCLISKA PROSTAGLANDINER |
| US4178367A (en) | 1977-02-21 | 1979-12-11 | Ono Pharmaceutical Co. Ltd. | Prostaglandin I2 analogues |
| AU524786B2 (en) * | 1977-03-07 | 1982-10-07 | The Upjohn Company | Prostacyclins |
| JPS53136513A (en) * | 1977-05-06 | 1978-11-29 | Ono Pharmaceut Co Ltd | Stabilization of prostaglandin-x-related compounds |
| US4219647A (en) | 1977-09-22 | 1980-08-26 | Josef Fried | Certain amides of prostacyclin and related compounds |
| JPS6022710B2 (en) * | 1977-09-16 | 1985-06-03 | 小野薬品工業株式会社 | Prostaglandin-like compounds |
| DE2743283A1 (en) * | 1977-09-27 | 1979-04-05 | Hoechst Ag | NEW PROSTACYCLIN ANALOG |
| IT1088036B (en) | 1977-11-25 | 1985-06-04 | Erba Carlo Spa | 15-EPI-PROSTACYCLINE AND ANALOG PROSTACYCLINE |
| US4705806A (en) * | 1978-02-13 | 1987-11-10 | Morton Jr Douglas R | Prostacyclin analogs |
| DE2811950A1 (en) * | 1978-03-18 | 1979-12-13 | Hoechst Ag | NEW PROSTACYCLIN ANALOGS |
| HU179001B (en) | 1978-05-29 | 1982-08-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing 5-halo-6,9alpha-oxido-prostaglandin derivatives |
| IT1099575B (en) * | 1978-07-20 | 1985-09-18 | Erba Carlo Spa | 20-METHYL-13,14-DEHYDRO-PGI2 'ITS SALTS AND ITS 16S- AND 16R-METHYL DERIVATIVES |
| DE2834248A1 (en) * | 1978-08-04 | 1980-02-28 | Hoechst Ag | NEW PROSTAGLAND DERIVATIVES IN THE DELTA 2-PGF TIEF 2 AND DELTA 2-PGE TIEF 2 SERIES |
| US4180657A (en) * | 1978-08-14 | 1979-12-25 | The Upjohn Company | Acyl-substituted phenyl esters of prostacyclin-type compounds |
| JPS56122372A (en) * | 1980-03-03 | 1981-09-25 | Toray Ind Inc | Prostaglandin i2 derivative |
| DE3029984C2 (en) * | 1980-08-08 | 1983-12-15 | Grünenthal GmbH, 5190 Stolberg | 2-Oxabicyclo [3.3.0] octane derivatives and medicinal products containing them |
| CH648556A5 (en) * | 1981-03-11 | 1985-03-29 | Hoffmann La Roche | FLUORPROSTACYCLINE. |
| AT381309B (en) * | 1982-05-27 | 1986-09-25 | Gruenenthal Gmbh | METHOD FOR PRODUCING 5Z-SHAPES OF 2,3,4-TRINOR-1,5-INTER-M-PHENYLENE-PROSTACYCLINDERIVA EN |
| JPS595155A (en) * | 1982-06-30 | 1984-01-12 | Ono Pharmaceut Co Ltd | Prostaglandin d-mimic compound, its preparation and antitumor agent containing the same |
| CA1324129C (en) * | 1987-04-30 | 1993-11-09 | Ryuzo Ueno | Prostaglandins of the f series |
| US5591887A (en) * | 1987-04-30 | 1997-01-07 | R-Tech Ueno, Ltd. | Prostaglandins of the F series |
| US5221763A (en) * | 1987-04-30 | 1993-06-22 | R-Tech Ueno, Ltd. | Prostaglandins of the F series |
| AU619543B2 (en) * | 1988-05-11 | 1992-01-30 | Sucampo Ag | Use of 15-ketoprostaglandin e or f compounds for uterine contraction |
| US5185374A (en) * | 1988-05-11 | 1993-02-09 | K.K. Ueno Seiyaku Oyo Kenkyujo | Use of 15-ketoprostaglandin E or F compounds for uterine contraction |
| DK2653468T3 (en) | 2009-07-28 | 2016-06-06 | Ono Pharmaceutical Co | Bicyclic compound AND USE THEREOF FOR MEDICAL PURPOSES |
| US9029574B2 (en) | 2011-01-27 | 2015-05-12 | Ono Pharmaceutical Co., Ltd. | Bicyclic compound and use thereof for medical purposes |
| CN116143742B (en) * | 2023-02-27 | 2024-10-18 | 广州楷石生物科技有限公司 | Epoprostenol Nitric Oxide Donor Drug |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2351112A1 (en) * | 1975-10-21 | 1977-12-09 | Wellcome Found | Prostaglandin derivs. |
| NL7705143A (en) * | 1976-05-11 | 1977-11-15 | Wellcome Found | PROCEDURE FOR PREPARING NEW PROSTAGLANDIN DERIVATIVES. |
| MX4813E (en) * | 1976-06-01 | 1982-10-19 | Upjohn Co | PROCEDURE FOR PREPARING ANALOGS OF PROSTAGLANDINAS |
| AU511711B2 (en) * | 1976-12-30 | 1980-09-04 | Upjohn Company, The | 6-Oxo and 5, 6-Dihalo prostaglandin analogues |
-
1976
- 1976-12-30 IL IL51189A patent/IL51189A/en unknown
-
1977
- 1977-01-11 NZ NZ183050A patent/NZ183050A/en unknown
- 1977-01-22 DE DE2702553A patent/DE2702553C2/en not_active Expired
- 1977-01-25 CA CA000270416A patent/CA1160627A/en not_active Expired
- 1977-01-27 GB GB3314/77A patent/GB1554044A/en not_active Expired
- 1977-01-28 NL NLAANVRAGE7700896,A patent/NL185515C/en not_active IP Right Cessation
- 1977-02-01 SE SE7701045A patent/SE435281B/en not_active IP Right Cessation
- 1977-02-03 FR FR7703076A patent/FR2359125B1/en not_active Expired
- 1977-02-03 JP JP52010332A patent/JPS5936911B2/en not_active Expired
- 1977-02-04 CH CH141677A patent/CH632245A5/en not_active IP Right Cessation
- 1977-02-04 BE BE174693A patent/BE851122A/en not_active IP Right Cessation
- 1977-10-26 FR FR7732282A patent/FR2362833A1/en active Granted
- 1977-10-26 FR FR7732283A patent/FR2362834A1/en active Granted
- 1977-11-04 MX MX775413U patent/MX4811E/en unknown
-
1978
- 1978-10-26 CA CA000349870A patent/CA1179335A/en not_active Expired
- 1978-10-26 CA CA000349868A patent/CA1160628A/en not_active Expired
-
1982
- 1982-04-02 CH CH206082A patent/CH637949A5/en not_active IP Right Cessation
-
1983
- 1983-07-01 NL NL8300921A patent/NL8300921A/en not_active Application Discontinuation
-
1985
- 1985-01-31 HK HK93/85A patent/HK9385A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL185515B (en) | 1989-12-01 |
| BE851122A (en) | 1977-08-04 |
| JPS5936911B2 (en) | 1984-09-06 |
| JPS5295644A (en) | 1977-08-11 |
| FR2362834A1 (en) | 1978-03-24 |
| IL51189A (en) | 1985-08-30 |
| FR2362833B1 (en) | 1980-08-08 |
| CA1160628A (en) | 1984-01-17 |
| NZ183050A (en) | 1979-06-08 |
| HK9385A (en) | 1985-02-08 |
| FR2359125A1 (en) | 1978-02-17 |
| MX4811E (en) | 1982-10-19 |
| IL51189A0 (en) | 1977-02-28 |
| DE2702553C2 (en) | 1986-02-20 |
| NL7700896A (en) | 1977-08-08 |
| CH632245A5 (en) | 1982-09-30 |
| FR2362834B1 (en) | 1980-08-08 |
| NL8300921A (en) | 1983-07-01 |
| DE2702553A1 (en) | 1977-08-18 |
| CH637949A5 (en) | 1983-08-31 |
| CA1179335A (en) | 1984-12-11 |
| FR2362833A1 (en) | 1978-03-24 |
| SE435281B (en) | 1984-09-17 |
| GB1554044A (en) | 1979-10-17 |
| CA1160627A (en) | 1984-01-17 |
| NL185515C (en) | 1990-05-01 |
| FR2359125B1 (en) | 1985-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1554044A (en) | Prostaglandins | |
| BE825655A (en) | IMPROVEMENTS FOR GASTRIC ACID SECRETION AGENTS | |
| NO902714D0 (en) | PROCEDURE FOR THE PREPARATION OF PHENYLEDIC DIETIC ACID DERIVATIVES OF TIENOPYRIDINES AND OF THE INTERMEDIATE ALFA BROMO-PHENYLEDIC ACIDS. | |
| KR830005216A (en) | Method for preparing imidazo [4,5-b] pyridine derivative | |
| FR2390433A1 (en) | COMPOUNDS USEFUL FOR THE PREPARATION OF PENICILLANIC ACID DERIVATIVES | |
| FR2385728A1 (en) | N-SULFOALKYL-AMINO-ALKANE-PHOSPHONIC ACIDS USED AS COMPLEXANTS | |
| FR2277891A1 (en) | METHOD TO DETECT BY RADIO-IMMUNOMETRY THE PRESENCE OF ANTIBODIES OF BLENNORRHAGIA | |
| FR2375239A1 (en) | 7-AMINO-8-OXO-3-OXA-1-AZABICYCLO- (4.2.0) OCTANE-2-CARBOXYLIC ACID DERIVATIVES | |
| GB1515019A (en) | Substituted imidazolidines and pharmaceutical uses thereo | |
| DE3263882D1 (en) | 11-deoxoglycyrrhetinic acid hydrogen maleate, process for its production, and its use as a medicine | |
| ATE39920T1 (en) | CYCLOPENTYL ETHER, PROCESS FOR THEIR PRODUCTION AND ITS PHARMACEUTICAL APPLICATION. | |
| ES455691A1 (en) | N-Benzhydryl-3-methyl-3-(dialkoxy)benzyl-piperazines | |
| JPS51149282A (en) | Process for preparing carbostyril derivatives | |
| GB1499901A (en) | Digitalis derivative and process for making the same | |
| SE7709477L (en) | PROCEDURE FOR PRODUCTION OF PROSTACYCLIN DERIVATIVES | |
| ES536973A0 (en) | METHOD OF PREPARING DIMETILOCTENONAS | |
| IE42478L (en) | Pharmaceutical composition | |
| SE7700172L (en) | PROCEDURE FOR PREPARING 2-OXOPYRROLIDINE-N-ALKANOYLAMIDE | |
| FR2445337A1 (en) | PROCESS AND INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF PROSTAGLANDIN DERIVATIVES | |
| FR2401137A1 (en) | (TRIALCOXY-3,5,5-PENTYNE-1-YL-1) - CYCLOHEXENE-1 AND APPLICATION TO THE PREPARATION OF ALDEHYDE IN 5 CORRESPONDING | |
| CH609024A5 (en) | Process for the preparation of new sulphur-containing diaryl and oxygen-containing diaryl compounds | |
| CH611601A5 (en) | Process for the preparation of new cyclopentane derivatives | |
| SE7602349L (en) | PROSTAGLAND INDIVIDUALS | |
| ES430790A1 (en) | Substituted keto-acids and esters and pharmaceutical uses thereof | |
| GB1231380A (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 7701045-2 Effective date: 19880125 Format of ref document f/p: F |